The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 2, 2012, Pages 151-160

  Krinsley, James S ^a   Meyfroidt, Geert ^b   Van Den Berghe, Greet ^b   Egi, Mori ^c   Bellomo, Rinaldo ^d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^d AUSTIN HOSPITAL   (Australia)

Author keywords

diabetes; glycemic variability; hyperglycemia; hypoglycemia; intensive care; mortality

Indexed keywords

INSULIN;

BLOOD GLUCOSE MONITORING; COHORT ANALYSIS; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; MORTALITY; PROGNOSIS; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES MELLITUS; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84857038560     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32834f0009     Document Type: Review

References (53)

1. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367.
2. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461. (Pubitemid 43200296)
3. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multicentre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol study. Int Care Med 2009; 35:1738-1748.
4. Brunkhorst F, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Eng J Med 2009; 358:125-139.
5. Arabi Y, Ousama D, Hani T, et al. Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008; 36:3190-3197.
6. The NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
7. Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endo Metab 2009; 94:3163-3170.
8. Desachy A, Vuagnat AC, Ghazali AD, et al. Accuracy of bedside glucometry in critically ill patients: Influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008; 83:400-405. (Pubitemid 351536465)
9. Corstjens AM, Lightenberg JJ, van der Horst IC, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care 2006; R135.
10. Vriesendorp T, DeVries JH, van Santen S, et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006; 34:2714-2718. (Pubitemid 44610935)
11. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007; 35:2262-2267. (Pubitemid 47476221)
12. Bagshaw S, Egi M, George C, Bellomo R. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009; 37:463-470.
13. Hermanides J, Bosman RJ, Vriesendorp TM. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med 2010; 38:1430-1434.
14. Egi M, Bellomo R, Stachowski E, et al. Hypoglycemia and outcome in critically ill patients. Mayo Clinic Proc 2010; 85:217-224. This observational cohort study from two ICUs demonstrated that mild hypoglycemia was independently associated with mortality.
15. Krinsley JS, Schultz MJ, Spronk PE, et al. Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care 2011; 15:R173. This international multicenter study, including observational as well as interventional trial data, confirmed the independent association of mild hypoglycemia, defined as blood glucose less than 70 mg/dl, with mortality in heterogeneous populations of critically ill patients.
16. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105:244-252. (Pubitemid 44148168)
17. Krinsley JS. Glycemic variability: A strong, independent risk factor for mortality in critically ill patients. Crit Care Med 2008; 36:3008-3013.
18. Bagshaw SM, Bellomo R, Jacka MJ, et al. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009; 13:R91.
19. Krinsley JS. Glycemic variability and mortality in critically ill patients: The impact of diabetes. J Diab Sci Tech 2009; 3:1292-1301.
20. Meyfroidt G, Keenan DM, Wang X, et al. Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010; 38:1021-1029. Pooled data from the surgical ICU and medical ICU trials of IIT performed in Leuven, Belgium, demonstrated that hypoglycemia as well as increased glycemic variability was independently associated with increased risk of mortality.
21. Hermanides J, Vriesendorp T, Bosman R, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010; 38:838-842.
22. Mackenzie I, Whitehouse T, Nightingale P. The metrics of glycaemic control in critical care. Int Care Med 2011; 37:435-443. This observational cohort study from several ICUs in a single academic institution demonstrated that hyperglycemia, hypoglycemia and increased glycemic variability had a cumulative association with increased risk of mortality.
23. Krinsley JS. Understanding glycemic control in the critically ill: Three domains are better than one. Int Care Med 2011; 37:382-384.
24. Rady MY, Johnson DJ, Patel BM, et al. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clinic Proc 2005; 80:1558-1567. (Pubitemid 41747057)
25. Krinsley JS. Glycemic control, diabetic status and mortality in a heterogeneous population of critically ill patients before and during the era of tight glycemic control. Semin Thorac Cardiovasc Surg 2006; 18:317-325.
26. Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: The impact of diabetes. Crit Care Med 2008; 36:2249-2255.
27. Graham BB, Keniston A, Gajic O, et al. Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med 2010; 38:16-24. This very large observational cohort study in heterogeneous populations of critically ill patients demonstrates that a premorbid diagnosis of diabetes did not confer an independent risk of mortality.
28. Krinsley JS. Untangling a sweet web: Hyperglycemia, diabetic status and mortality in critically ill patients. Crit Care Med 2010; 38:295-296.
29. Egi M, Bellomo R, Stachowski E, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011; 39:105-111. This observational cohort study demonstrated the relationship between premorbid glycemic control and glycemic control during critical illness in a cohort of patients with known diabetes.
30. Falciglia M, Freyberg R, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009; 37:3001-3009.
31. Peterson KP, Pavlovich JG, Goldstein D, et al. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem 1998; 44:1951-1958. (Pubitemid 28405762)
32. Rohlfing CL, Wiedmeyer HM, Little RR, et al. Defining the relationship between plasma glucose and HbA(1c): Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diab Care 2002; 25:275-278. (Pubitemid 41079621)
33. Joosten SA, Koh MS, Bu X, et al. The effects of oxygen therapy in patients presenting to an emergency department with exacerbation of chronic obstructive pulmonary disease. Med J Aust 2007; 186:235-238. (Pubitemid 46421440)
34. Widdess-Walsh P, Sabharwal V, Demirjian S, DeGeorgia M. Neurologic effects of hyponatremia and its treatment. Cleve Clin J Med 2007; 74:377-383.
35. Shuaib A. Alteration of blood pressure regulation and cerebrovascular disorders in the elderly. Cerebrovasc Brain Metab Rev 1992; 4:329-345.
36. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559. (Pubitemid 351831356)
37. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572. (Pubitemid 351831357)
38. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008; 358:2630-2633. (Pubitemid 351831365)
39. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34:96-101. (Pubitemid 43032385)
40. Dotson S, Freeman R, Failing HJ, et al. Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diab Care 2008; 31:1222-1223.
41. Schlenk F, Graetz D, Nagel A, et al. Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Crit Care 2008; 12:R9.
42. Keller-Wood ME, Shinsako J, Dallman MF. Inhibition of the adrenocorticotropin and corticosteroid responses to hypoglycemia after prior stress. Endocrinology 1983; 113:491-496. (Pubitemid 13048936)
43. Herlein JA, Morgan DA, Phillips BG, et al. Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responses. Endocrinology 2006; 147:2781-2788. (Pubitemid 43764615)
44. Dieguez G, Fernandez N, Garcia JL, et al. Role of nitric oxide in the effects of hypoglycemia on the cerebral circulation in awake goats. Eur J Pharmacol 1997; 330:185-193. (Pubitemid 27296721)
45. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-Associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993; 91:819-828. (Pubitemid 23095255)
46. Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52:2795-2804. (Pubitemid 37339710)
47. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295:1681-1687.
48. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54:1615-1625. (Pubitemid 40770750)
49. Watada H, Azuma K, Kawamori R. Glucose fluctuation on the progression of diabetic macroangiopathy: New findings from monocyte adhesion to endothelial cells. Diabetes Res Clin Pract 2007; 77 (Suppl 1):S58-S61. (Pubitemid 47212554)
50. Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001; 281:E924-E930.
51. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373:547-556.
52. Vanhorebeek I, Gielen M, Boussemaere M, et al. Glucose dysregulation and neurological injury biomarkers in critically ill children. J Clin Endocrinol Metab 2010; 95:4669-4679.
53. Joseph JI, Hipszer B, Mraovic B, et al. Clinical need for continuous glucose monitoring in the hospital. J Diab Sci Tech 2009; 3:1309-1318.